Place · Level 3 · Adaptogen
Adaptogens & Medicinal Mushrooms
Selye 应激概念 · 苏联军用历史 · 狮鬃菇、红景天、灵芝、冬虫夏草、五味子 · 大多 C-D 级 · 营销远超证据
Last updated
Story path
Chapter 1
Adaptogen framework
Adaptogen framework
"Adaptogens" is a vague but commercially powerful concept now applied to dozens of plants + mushrooms, with a global market of $20B+/year.
Origin of the concept:
Hans Selye (1930s-40s): "general adaptation syndrome (GAS)" — three stages of chronic stress (alarm → resistance → exhaustion)Nikolai Lazarev (1947 USSR): coined the word "adaptogen" for "plants that increase non-specific resistance to physical / chemical / biological stress"Soviet military / space program use: Eleutherococcus (Siberian "ginseng") + Rhodiola + Schisandra — large-scale 1950s-80s research + clinical useWestern adoption: entered the nutritional-supplement market in the 1990s, now mainstream
Official definition (Brekhman 1969, ESCOP):
1. Non-specifically enhances stress resistance
2. Normalising effect (raises the low, lowers the high)
3. No toxicity (at therapeutic doses)
But this definition is problematic:
"Non-specific": nearly impossible to measure precisely in RCTs"Normalising": sounds magical, in fact hard to falsifyModern pharmacology does not recognise the category: too many mechanisms + endpoints too soft
The 10 most-marketed adaptogens:
1. Ashwagandha (Withania somnifera) — covered in atlas ashwagandha story (Ayurveda)
2. Rhodiola rosea — Soviet military, Nordic / Tibetan wild
3. Panax ginseng (Asian, American) — China / Korea / USA
4. Eleutherococcus senticosus (Siberian "ginseng") — not a true ginseng
5. Holy Basil (Tulsi, Ocimum sanctum) — Ayurveda
6. Schisandra chinensis — China / USSR
7. Lion's Mane (Hericium erinaceus) — Japan / China
8. Reishi (Ganoderma lucidum) — China / Japan
9. Cordyceps (sinensis / militaris) — China / Tibet
10. Chaga (Inonotus obliquus) — north Russia / Siberia
The structure of the "adaptogen craze" marketing:
Cross-platform promotion on TikTok / Instagram / YouTube"Natural = safe + effective" rhetoric"Holistic / integrative / traditional wisdom" framing"Anti-stress + immunity-boosting + focus + anti-ageing" universal claimsPrice premium ($30-80/month per item) → combination formulas cost more
Atlas position: this island acknowledges the partial historical truth of the adaptogen concept but rigorously evaluates each product by evidence level — most are Level C-D, a few are Level B, almost none Level A.
Origin of the concept:
Hans Selye (1930s-40s): "general adaptation syndrome (GAS)" — three stages of chronic stress (alarm → resistance → exhaustion)Nikolai Lazarev (1947 USSR): coined the word "adaptogen" for "plants that increase non-specific resistance to physical / chemical / biological stress"Soviet military / space program use: Eleutherococcus (Siberian "ginseng") + Rhodiola + Schisandra — large-scale 1950s-80s research + clinical useWestern adoption: entered the nutritional-supplement market in the 1990s, now mainstream
Official definition (Brekhman 1969, ESCOP):
1. Non-specifically enhances stress resistance
2. Normalising effect (raises the low, lowers the high)
3. No toxicity (at therapeutic doses)
But this definition is problematic:
"Non-specific": nearly impossible to measure precisely in RCTs"Normalising": sounds magical, in fact hard to falsifyModern pharmacology does not recognise the category: too many mechanisms + endpoints too soft
The 10 most-marketed adaptogens:
1. Ashwagandha (Withania somnifera) — covered in atlas ashwagandha story (Ayurveda)
2. Rhodiola rosea — Soviet military, Nordic / Tibetan wild
3. Panax ginseng (Asian, American) — China / Korea / USA
4. Eleutherococcus senticosus (Siberian "ginseng") — not a true ginseng
5. Holy Basil (Tulsi, Ocimum sanctum) — Ayurveda
6. Schisandra chinensis — China / USSR
7. Lion's Mane (Hericium erinaceus) — Japan / China
8. Reishi (Ganoderma lucidum) — China / Japan
9. Cordyceps (sinensis / militaris) — China / Tibet
10. Chaga (Inonotus obliquus) — north Russia / Siberia
The structure of the "adaptogen craze" marketing:
Cross-platform promotion on TikTok / Instagram / YouTube"Natural = safe + effective" rhetoric"Holistic / integrative / traditional wisdom" framing"Anti-stress + immunity-boosting + focus + anti-ageing" universal claimsPrice premium ($30-80/month per item) → combination formulas cost more
Atlas position: this island acknowledges the partial historical truth of the adaptogen concept but rigorously evaluates each product by evidence level — most are Level C-D, a few are Level B, almost none Level A.
Origin of the concept
适应原 (adaptogen) 这个词是苏联药理学家 Lazarev 1947 年造的, 底子是 Selye 更早提出的应激三阶段。苏联军队和太空计划拿红景天、五味子这类植物做过大量研究, 1990s 传入西方补剂市场后成了主流。历史背景就这些——它解释了这个标签为什么听上去像科学, 但回答不了下一个问题: 适应原到底声称在你身体里做了什么?
官方定义为什么推不翻
Brekhman 1969 年提出、后来被 ESCOP 沿用的官方定义给出三条标准:1. 非特异性增强抗应激能力
2. 正常化作用 (高的降, 低的升)
3. 治疗剂量下无毒副
问题恰恰出在这三条自己身上: 非特异性 几乎无法在 RCT 中精确测量;正常化 听起来神奇, 实际很难证伪——不管结果往哪边走, 都能算它说对了。现代药理学不承认这一大类, 正是因为机制太杂、终点太软。
The structure of the "adaptogen craze" marketing
适应原热潮 的营销结构基本是固定的: TikTok / Instagram / YouTube 全平台推广,自然 = 安全 + 有效 的修辞,整全、整体、传统智慧 的故事化,抗应激 + 提升免疫 + 提专注 + 抗衰 的万能宣传, 以及 $30-80/月单品的价格溢价, 复合配方更贵。挂着适应原 名头的还有一长串 (人参、西伯利亚人参、圣罗勒、五味子、白桦茸等), 名字花哨但人体证据更薄, 这里不逐个展开。这一岛承认适应原概念的部分真实历史, 但严格用证据等级评估每个单品: 大多数 C-D 级, 少数 B 级, 几乎没有 A 级。
Chapter 2
Lion's Mane · NGF reality
Lion's Mane · NGF reality
Lion's Mane (Hericium erinaceus) — one of the largest single items in the 2020s adaptogen market:
Traditional use:
Medicinal mushroom in China + Japan (yamabushitake)Both food + medicinal
Marketing core (driven by TikTok / Huberman):
"Promotes NGF (nerve growth factor) → neural regeneration → anti-dementia / cognitive enhancement / antidepressant""Holistic brain health""Like modafinil but natural"
Actual evidence:
① In-vitro + animal (Lai 2013 + Mori 2008, etc.):
Lion's Mane extracts do stimulate NGF expression in cell cultureHericenones + Erinacines are the main compoundsMouse models: partly positive in nerve-injury + dementia models
② Human clinical (far less than animal):
Mori 2008 Phytother Res (N = 30 mild cognitive impairment, age 50-80): 16 weeks 3 g/day → MMSE improved, returned to baseline after stoppingSaitsu 2019 Biomed Res (N = 31 healthy): 12 weeks → some cognitive improvementSmall samples + mostly Japanese studies + much commercial funding
Key issues:
"NGF crossing the blood-brain barrier" lacks evidenceHericenones / Erinacines in-vivo NGF signalling mechanism (in humans) is not fully establishedLarge RCTs lacking"Long-term prevention of dementia" has no evidence whatsoever
Debunking "modafinil alternative" marketing:
Modafinil: dopamine / histamine / orexin modulation, potent nootropic, prescriptionLion's Mane: entirely different mechanism, effect much weaker than modafinil (no large head-to-head trial, but reasonable inference)The "natural modafinil" framing is overstated
Potential benefits (honest assessment):
Level C-B evidence for mild cognitive impairment adjunct (older adults)Level B-C for healthy nootropic effects (subjective sensation)Level D for dementia preventionFood: nutritional value similar to shiitake / king oyster + a few distinctive neuroactive compounds
Dose + form:
Dry extract 500-1500 mg × 2/day"Fruit body" vs "mycelium": most studies use fruit body, commercial products often use mycelium (cheaper but fewer hericenones)Quality variability: prioritise third-party-tested + large brands
Safety:
Very safe (food-grade)Allergy: rare (mushroom-allergic individuals beware)Pregnancy: data lacking
Atlas position: Lion's Mane is the classic case of "plausible mechanistic signal + weak clinical evidence + heavy marketing". As a food it has value, but don't pay a premium for "anti-dementia".
Traditional use:
Medicinal mushroom in China + Japan (yamabushitake)Both food + medicinal
Marketing core (driven by TikTok / Huberman):
"Promotes NGF (nerve growth factor) → neural regeneration → anti-dementia / cognitive enhancement / antidepressant""Holistic brain health""Like modafinil but natural"
Actual evidence:
① In-vitro + animal (Lai 2013 + Mori 2008, etc.):
Lion's Mane extracts do stimulate NGF expression in cell cultureHericenones + Erinacines are the main compoundsMouse models: partly positive in nerve-injury + dementia models
② Human clinical (far less than animal):
Mori 2008 Phytother Res (N = 30 mild cognitive impairment, age 50-80): 16 weeks 3 g/day → MMSE improved, returned to baseline after stoppingSaitsu 2019 Biomed Res (N = 31 healthy): 12 weeks → some cognitive improvementSmall samples + mostly Japanese studies + much commercial funding
Key issues:
"NGF crossing the blood-brain barrier" lacks evidenceHericenones / Erinacines in-vivo NGF signalling mechanism (in humans) is not fully establishedLarge RCTs lacking"Long-term prevention of dementia" has no evidence whatsoever
Debunking "modafinil alternative" marketing:
Modafinil: dopamine / histamine / orexin modulation, potent nootropic, prescriptionLion's Mane: entirely different mechanism, effect much weaker than modafinil (no large head-to-head trial, but reasonable inference)The "natural modafinil" framing is overstated
Potential benefits (honest assessment):
Level C-B evidence for mild cognitive impairment adjunct (older adults)Level B-C for healthy nootropic effects (subjective sensation)Level D for dementia preventionFood: nutritional value similar to shiitake / king oyster + a few distinctive neuroactive compounds
Dose + form:
Dry extract 500-1500 mg × 2/day"Fruit body" vs "mycelium": most studies use fruit body, commercial products often use mycelium (cheaper but fewer hericenones)Quality variability: prioritise third-party-tested + large brands
Safety:
Very safe (food-grade)Allergy: rare (mushroom-allergic individuals beware)Pregnancy: data lacking
Atlas position: Lion's Mane is the classic case of "plausible mechanistic signal + weak clinical evidence + heavy marketing". As a food it has value, but don't pay a premium for "anti-dementia".
Actual evidence
培养皿和动物: Lai 2013、Mori 2008 等研究里, 狮鬃菇提取物确实在培养皿中刺激 NGF 表达, Hericenones + Erinacines 是主要化合物; 在神经损伤和痴呆的小鼠模型里也有部分阳性。人体: 远少于动物。Mori 2008 Phytother Res (N=30 轻度认知障碍老人, 50-80 岁) 16 周 3 g/天, MMSE 评分改善, 停药后回到基线。Saitsu 2019 Biomed Res (N=31 健康) 12 周, 部分认知改善。整体看是小样本 + 主要日本研究 + 商业资金多。
大型 RCT 缺乏,长期使用预防痴呆 完全没有证据支持。
Debunking "modafinil alternative" marketing
Debunking "modafinil alternative" marketing:Modafinil: dopamine / histamine / orexin modulation, potent nootropic, prescriptionLion's Mane: entirely different mechanism, effect much weaker than modafinil (no large head-to-head trial, but reasonable inference)The "natural modafinil" framing is overstated
Potential benefits (honest assessment):
Level C-B evidence for mild cognitive impairment adjunct (older adults)Level B-C for healthy nootropic effects (subjective sensation)Level D for dementia preventionFood: nutritional value similar to shiitake / king oyster + a few distinctive neuroactive compounds
Dose + form
剂量和形态: 干提取物 500-1500 mg × 2次/天。子实体 (fruit body) 和菌丝体 (mycelium) 要分清——大多研究用子实体, 商品多用菌丝体, 便宜但 hericenone 较少。质量参差, 优先选第三方测试 + 大品牌。安全: 极安全 (食物级别); 蘑菇过敏者注意罕见过敏; 怀孕缺数据。
Chapter 3
Rhodiola · stress + fatigue
Rhodiola · stress + fatigue
Rhodiola rosea — one of the most-researched adaptogens in Soviet / Nordic studies:
Traditional use:
Tibet / Nordic / Siberia high-altitude traditional medicineSoviet military 1947-1991 extensive research + space + military use
Main actives:
Rosavin + salidroside (standardised extract)Common standard: SHR-5 (3% rosavin + 1% salidroside)
Clinical evidence (relatively strong among adaptogens):
Olsson 2009 Planta Med RCT (N = 60 chronic fatigue): 4 weeks → improved fatigue + attentionHung 2011 Phytomedicine review: multiple RCTs (but small + mainly Eastern European / Russian)Cropley 2015 J Altern Complement Med RCT (N = 80): 14 days → ↓ self-reported stressPunja 2014 Hum Psychopharmacol meta: 11 RCTs, partly positive (mild-to-moderate depression + chronic fatigue)
Level B evidence (relatively good among adaptogens):
Chronic fatigue / stress burnoutMild depression (adjunct)Exercise performance (endurance): some small positive trials
Mechanism (hypothesised, partly established):
hypothalamic–pituitary–adrenal axis: The body's stress-response chain (hypothalamus → pituitary → adrenal) that releases cortisol.-axis modulation (similar to ashwagandha)Mild 5-HT / DA neurotransmitter modulationβ-endorphinAMP-activated protein kinase: The cell's 'low fuel' sensor — switches on when energy is low to make energy and pause building. pathway
Dose:
200-600 mg/day standardised SHR-5Take in the morning (evening dosing may disrupt sleep)2-6 weeks to evaluate effect
Debunking "Rhodiola = natural modafinil":
Different mechanism, different magnitudeNot an "acute cognitive booster"Real use: adjunct for chronic stress / burnout / chronic fatigue
Safety:
Generally well-toleratedInsomnia / agitation / headache (high doses)Bipolar / mania history: caution (similar to ashwagandha)SSRI / SNRI: theoretical serotonin-syndrome risk, discuss with psychiatryAnticoagulants (warfarin): Rhodiola may mildly interact, monitor
Comparison with ashwagandha:
Ashwagandha: more GABA / sedation / cortisol ↓ (evening dose)Rhodiola: more arousal / anti-fatigue (morning dose)Some people combine (Rhodiola morning + Ashwagandha evening)
Atlas position: Rhodiola has relatively the strongest Level B evidence among adaptogens, well-suited as an adjunct for chronic stress / fatigue / burnout. Does not replace depression treatment + real rest + stressor management.
Traditional use:
Tibet / Nordic / Siberia high-altitude traditional medicineSoviet military 1947-1991 extensive research + space + military use
Main actives:
Rosavin + salidroside (standardised extract)Common standard: SHR-5 (3% rosavin + 1% salidroside)
Clinical evidence (relatively strong among adaptogens):
Olsson 2009 Planta Med RCT (N = 60 chronic fatigue): 4 weeks → improved fatigue + attentionHung 2011 Phytomedicine review: multiple RCTs (but small + mainly Eastern European / Russian)Cropley 2015 J Altern Complement Med RCT (N = 80): 14 days → ↓ self-reported stressPunja 2014 Hum Psychopharmacol meta: 11 RCTs, partly positive (mild-to-moderate depression + chronic fatigue)
Level B evidence (relatively good among adaptogens):
Chronic fatigue / stress burnoutMild depression (adjunct)Exercise performance (endurance): some small positive trials
Mechanism (hypothesised, partly established):
hypothalamic–pituitary–adrenal axis: The body's stress-response chain (hypothalamus → pituitary → adrenal) that releases cortisol.-axis modulation (similar to ashwagandha)Mild 5-HT / DA neurotransmitter modulationβ-endorphinAMP-activated protein kinase: The cell's 'low fuel' sensor — switches on when energy is low to make energy and pause building. pathway
Dose:
200-600 mg/day standardised SHR-5Take in the morning (evening dosing may disrupt sleep)2-6 weeks to evaluate effect
Debunking "Rhodiola = natural modafinil":
Different mechanism, different magnitudeNot an "acute cognitive booster"Real use: adjunct for chronic stress / burnout / chronic fatigue
Safety:
Generally well-toleratedInsomnia / agitation / headache (high doses)Bipolar / mania history: caution (similar to ashwagandha)SSRI / SNRI: theoretical serotonin-syndrome risk, discuss with psychiatryAnticoagulants (warfarin): Rhodiola may mildly interact, monitor
Comparison with ashwagandha:
Ashwagandha: more GABA / sedation / cortisol ↓ (evening dose)Rhodiola: more arousal / anti-fatigue (morning dose)Some people combine (Rhodiola morning + Ashwagandha evening)
Atlas position: Rhodiola has relatively the strongest Level B evidence among adaptogens, well-suited as an adjunct for chronic stress / fatigue / burnout. Does not replace depression treatment + real rest + stressor management.
从西伯利亚到苏联军方
传统使用: 西藏、北欧、西伯利亚高海拔地区的传统药用植物; 苏联军方在 1947-1991 期间做了大量研究, 并在太空和军事场景应用。主要活性: Rosavin + Salidroside; 临床上常用的标准化提取物是 SHR-5 (3% rosavin + 1% salidroside)。
Clinical evidence (relatively strong among adaptogens)
Olsson 2009 Planta Med RCT (N=60 慢性疲劳): 4 周, 疲劳和注意力改善。Hung 2011 Phytomedicine 综述: 多个 RCT, 但样本小, 主要来自东欧、俄罗斯。Cropley 2015 J Altern Complement Med RCT (N=80): 14 天, 自评压力 ↓。Punja 2014 Hum Psychopharmacol meta: 11 RCT, 部分阳性 (轻-中度抑郁 + 慢性疲劳)。这些 B 级证据 (相对其他适应原好) 集中在三处: 慢性疲劳和应激倦怠、轻度抑郁辅助、运动耐力 (部分小试验阳性)。
剂量: 200-600 mg/天 SHR-5 标准化; 早上服 (晚服可能影响睡眠); 2-6 周看效果。
安全 · 和 ashwagandha 怎么分工
Safety:Generally well-toleratedInsomnia / agitation / headache (high doses)Bipolar / mania history: caution (similar to ashwagandha)SSRI / SNRI: theoretical serotonin-syndrome risk, discuss with psychiatryAnticoagulants (warfarin): Rhodiola may mildly interact, monitor
Comparison with ashwagandha:
Ashwagandha: more GABA / sedation / cortisol ↓ (evening dose)Rhodiola: more arousal / anti-fatigue (morning dose)Some people combine (Rhodiola morning + Ashwagandha evening)
Chapter 4
Reishi + cordyceps
Reishi + cordyceps
Reishi (Ganoderma lucidum) + Cordyceps (sinensis / militaris) — celebrated Chinese traditional materia medica, hot in modern marketing.
Reishi:
Tradition: "the divine mushroom" in China + "mannentake" in Japan; Daoist immortality legend
Main actives: β-glucans + triterpenoids + ergosterol
Clinical evidence:
Immunomodulation: small trials (Tang 2005, Gao 2003) show NK-cell + cytokine modulationFatigue / neurasthenia (Tang 2005 RCT): moderately positiveChemotherapy adjunct (improves quality of life, not direct anti-tumor): Cochrane 2016 meta-analysis weakly positiveLipid / cardiovascular: weak signal"Holistic anti-ageing / anti-cancer" marketing: no Level A evidence
Dose:
Dry extract 1.5-9 g/day (Chinese traditional higher)Polysaccharide content 30%+ extract preferred
Safety:
Generally well-toleratedMay be mildly anticoagulant / antiplatelet, caution with warfarin / pre-surgeryAllergy / GI: occasional
Debunking "reishi treats tumors":
Used by some Chinese cancer patients as an "adjunct"Does not replace chemotherapy / radiotherapy / surgery2016 Cochrane: evidence for quality-of-life improvement; direct anti-tumor evidence is weak
Cordyceps:
Tradition: high-altitude China + Tibet, fungus + ghost-moth larva (wild), 500 g of wild form costs ¥100,000-500,000
Cultivated: Cordyceps militaris (chrysalis Cordyceps) — the main commercial form
Main actives: cordycepin + adenosine + polysaccharides
Clinical evidence:
Exercise performance (endurance + VO₂max): small trials (Hirsch 2017 J Diet Suppl) show signal but mixedFatigue / sexual function: weak evidenceRenal protection (CKD): some TCM research, Western evidence weak"Anti-ageing / anti-tumor / cure-all": marketing, lacks Level A-B evidence
"Wild cordyceps is magical" vs "cultivated":
Wild (sinensis): extremely expensive, serious heavy-metal (As / Cd) contamination risk, partially restricted by Chinese regulatorsCultivated (militaris): cheap + standardised + similar activity; modern real-world useThe "wild is better" narrative is clinically equivalent but carries greater contamination risk
Dose:
1-3 g/day standardised extract
Safety:
Generally safe (cultivated)Wild heavy-metal warningAutoimmune disease: immunomodulatory risk
Cordyceps + Reishi combinations:
Common in TCM + supplement combinationsEach has weak individual clinical evidence; no large RCT for combined synergyLarge price premium; combination formulas are not recommended
Reishi:
Tradition: "the divine mushroom" in China + "mannentake" in Japan; Daoist immortality legend
Main actives: β-glucans + triterpenoids + ergosterol
Clinical evidence:
Immunomodulation: small trials (Tang 2005, Gao 2003) show NK-cell + cytokine modulationFatigue / neurasthenia (Tang 2005 RCT): moderately positiveChemotherapy adjunct (improves quality of life, not direct anti-tumor): Cochrane 2016 meta-analysis weakly positiveLipid / cardiovascular: weak signal"Holistic anti-ageing / anti-cancer" marketing: no Level A evidence
Dose:
Dry extract 1.5-9 g/day (Chinese traditional higher)Polysaccharide content 30%+ extract preferred
Safety:
Generally well-toleratedMay be mildly anticoagulant / antiplatelet, caution with warfarin / pre-surgeryAllergy / GI: occasional
Debunking "reishi treats tumors":
Used by some Chinese cancer patients as an "adjunct"Does not replace chemotherapy / radiotherapy / surgery2016 Cochrane: evidence for quality-of-life improvement; direct anti-tumor evidence is weak
Cordyceps:
Tradition: high-altitude China + Tibet, fungus + ghost-moth larva (wild), 500 g of wild form costs ¥100,000-500,000
Cultivated: Cordyceps militaris (chrysalis Cordyceps) — the main commercial form
Main actives: cordycepin + adenosine + polysaccharides
Clinical evidence:
Exercise performance (endurance + VO₂max): small trials (Hirsch 2017 J Diet Suppl) show signal but mixedFatigue / sexual function: weak evidenceRenal protection (CKD): some TCM research, Western evidence weak"Anti-ageing / anti-tumor / cure-all": marketing, lacks Level A-B evidence
"Wild cordyceps is magical" vs "cultivated":
Wild (sinensis): extremely expensive, serious heavy-metal (As / Cd) contamination risk, partially restricted by Chinese regulatorsCultivated (militaris): cheap + standardised + similar activity; modern real-world useThe "wild is better" narrative is clinically equivalent but carries greater contamination risk
Dose:
1-3 g/day standardised extract
Safety:
Generally safe (cultivated)Wild heavy-metal warningAutoimmune disease: immunomodulatory risk
Cordyceps + Reishi combinations:
Common in TCM + supplement combinationsEach has weak individual clinical evidence; no large RCT for combined synergyLarge price premium; combination formulas are not recommended
灵芝 · 传统与临床证据
传统上中国称灵芝为仙草, 日本称万年茸, 与道家长生不老的传说绑在一起。主要活性: β-葡聚糖 + 三萜类 + 麦角甾醇。临床证据:
免疫调节: 部分小试验 (Tang 2005, Gao 2003) 显示 NK 细胞和细胞因子调节疲劳、神经衰弱 (Tang 2005 RCT): 中等阳性化疗辅助 (改善生活质量, 不直接抗肿瘤): Cochrane 2016 meta 弱阳性降胆固醇、心血管: 弱信号整全抗衰、抗癌 营销说法: 没有 A 级证据
灵芝 · 剂量、安全, 和肿瘤那句话
剂量: 干提取物 1.5-9 g/天 (中国传统更高); 多糖含量 30%+ 的提取物较优。安全: 大多耐受良好; 可能轻度抗凝、抗血小板, 服华法林或手术前要慎用; 过敏或胃肠反应偶见。
关于灵芝可治肿瘤: 中国部分肿瘤患者把它当辅助使用, 不能替代化疗、放疗或手术。2016 Cochrane 综述显示, 灵芝改善生活质量的证据存在, 但直接抗肿瘤的证据较弱。
冬虫夏草 · 从虫到药, 证据到哪
冬虫夏草 的传统形式来自中国和西藏高山——真菌 + 蝙蝠蛾幼虫的天然组合, 一斤野生重 ¥10-50 万。现代多用人工培养的 *Cordyceps militaris* (蛹虫草), 是主要营销品。主要活性: Cordycepin + Adenosine + 多糖。临床证据:
运动表现 (耐力 + VO₂max): 部分小试验 (Hirsch 2017 J Diet Suppl) 显示信号, 但结果混合疲劳、性功能: 弱证据肾保护 (CKD): 部分中医研究, 西方证据弱抗衰、抗肿瘤、全能: 营销说法, 缺 A-B 级证据
剂量: 1-3 g/天标准化提取物。安全: 人工培养形式大多安全; 野生形式有重金属警告; 自身免疫病患者要注意免疫调节风险。
"Wild cordyceps is magical" vs "cultivated"
"Wild cordyceps is magical" vs "cultivated":Wild (sinensis): extremely expensive, serious heavy-metal (As / Cd) contamination risk, partially restricted by Chinese regulatorsCultivated (militaris): cheap + standardised + similar activity; modern real-world useThe "wild is better" narrative is clinically equivalent but carries greater contamination risk
Cordyceps + Reishi combinations:
Common in TCM + supplement combinationsEach has weak individual clinical evidence; no large RCT for combined synergyLarge price premium; combination formulas are not recommended
Chapter 5
Decision tree + marketing debunk
Decision tree + marketing debunk
Adaptogen / medicinal-mushroom decisions:
Q1: What is your goal?
Chronic stress / burnout: Rhodiola has the strongest Level B evidence; Ashwagandha (atlas) Level B; try one for 6-8 weeksMild depression adjunct: Rhodiola; does not replace SSRI / psychotherapyCognition / memory: Lion's Mane Level C-B, try for 12 weeks; effect is far smaller than exercise + sleep + dietImmune modulation / chronic-disease adjunct: Reishi Level C, combine with conventional medicineExercise endurance: Cordyceps weak signal, don't expect large effect"Anti-ageing" / "longevity": no adaptogen meets the bar, don't buy
Q2: Practical use:
Try one at a time, no combination: combinations make it impossible to know what's workingEvaluate at 2-8 weeks: subjective sensation + stress / fatigue scalesThird-party certification: USP / NSF / EurofinsStandardised extracts: not "whole powder" / "whole spectrum"
Q3: Debunking marketing claims:
"Universal adaptogen regulation": too vague, real per-item effects are narrow"Holistic wisdom + ancient tradition": a long history does not equal strong modern evidence"Natural is safe": wrong, debunked many times in the atlas"Gentler than drugs but just as effective": partly true, mostly wrong"Anti-dementia / anti-tumor / anti-viral universal": severely overstated"Combination synergy": virtually no large RCT support
Safety warnings (all adaptogens):
Pregnancy / breastfeeding: most lack data, skipBipolar / mania history: some can induce / worsenOn SSRI / SNRI / MAOI: theoretical serotonin-syndrome riskAnticoagulants (warfarin / DOACs): some adaptogens are antiplatelet / affect coagulationStop 1-2 weeks before surgeryAutoimmune disease (RA / SLE / Hashimoto's): some adaptogens activate immunity → caution
Atlas meta-position (emphasised):
True "adaptogenic" interventions (with evidence):
Exercise (atlas exercise) → real stress adaptationSleep → real hypothalamic–pituitary–adrenal axis: The body's stress-response chain (hypothalamus → pituitary → adrenal) that releases cortisol. repairMindfulness + CBT → real stress resetSauna + cold exposure (atlas heat-cold) → hormesisDietary structure (low UPF + Mediterranean) → ↓ chronic inflammationSocial + relationships
These are the "real adaptogens" — 5-10× stronger than any plant / mushroom extract, zero cost, zero side effects.
Where supplement adaptogens reasonably fit:
Foundations are in place + still room to improve + realistic use commitment (8-12 weeks) + objective evaluationNot "I'm stressed so I take X" — that is using supplements to avoid the real issue
Cost-benefit analysis:
Ashwagandha ($15-30/month) + Rhodiola ($20-40/month): the same money on CBT apps / gym / nutrition counselling has higher ROI"Most expensive = best supplement" is usually a marketing premium — extract standardisation quality matters more
Connections to other atlas stories:
ashwagandha L4 (HPA + cortisol)endocrine/HPA + metabolic-syndrome (stress metabolism)insomnia + shift-work-circadian (sleep + rhythm)depression-anxiety + exercise (mental health)caffeine-l-theanine + alpha-gpc-cdp-choline (nootropic family)
Summary: the adaptogen field does include a few Level B-evidence items, but overall marketing far exceeds evidence. The atlas neither sells fear nor sells perfection — evaluate each item independently by evidence level, build foundations first, then consider supplements if room remains.
Q1: What is your goal?
Chronic stress / burnout: Rhodiola has the strongest Level B evidence; Ashwagandha (atlas) Level B; try one for 6-8 weeksMild depression adjunct: Rhodiola; does not replace SSRI / psychotherapyCognition / memory: Lion's Mane Level C-B, try for 12 weeks; effect is far smaller than exercise + sleep + dietImmune modulation / chronic-disease adjunct: Reishi Level C, combine with conventional medicineExercise endurance: Cordyceps weak signal, don't expect large effect"Anti-ageing" / "longevity": no adaptogen meets the bar, don't buy
Q2: Practical use:
Try one at a time, no combination: combinations make it impossible to know what's workingEvaluate at 2-8 weeks: subjective sensation + stress / fatigue scalesThird-party certification: USP / NSF / EurofinsStandardised extracts: not "whole powder" / "whole spectrum"
Q3: Debunking marketing claims:
"Universal adaptogen regulation": too vague, real per-item effects are narrow"Holistic wisdom + ancient tradition": a long history does not equal strong modern evidence"Natural is safe": wrong, debunked many times in the atlas"Gentler than drugs but just as effective": partly true, mostly wrong"Anti-dementia / anti-tumor / anti-viral universal": severely overstated"Combination synergy": virtually no large RCT support
Safety warnings (all adaptogens):
Pregnancy / breastfeeding: most lack data, skipBipolar / mania history: some can induce / worsenOn SSRI / SNRI / MAOI: theoretical serotonin-syndrome riskAnticoagulants (warfarin / DOACs): some adaptogens are antiplatelet / affect coagulationStop 1-2 weeks before surgeryAutoimmune disease (RA / SLE / Hashimoto's): some adaptogens activate immunity → caution
Atlas meta-position (emphasised):
True "adaptogenic" interventions (with evidence):
Exercise (atlas exercise) → real stress adaptationSleep → real hypothalamic–pituitary–adrenal axis: The body's stress-response chain (hypothalamus → pituitary → adrenal) that releases cortisol. repairMindfulness + CBT → real stress resetSauna + cold exposure (atlas heat-cold) → hormesisDietary structure (low UPF + Mediterranean) → ↓ chronic inflammationSocial + relationships
These are the "real adaptogens" — 5-10× stronger than any plant / mushroom extract, zero cost, zero side effects.
Where supplement adaptogens reasonably fit:
Foundations are in place + still room to improve + realistic use commitment (8-12 weeks) + objective evaluationNot "I'm stressed so I take X" — that is using supplements to avoid the real issue
Cost-benefit analysis:
Ashwagandha ($15-30/month) + Rhodiola ($20-40/month): the same money on CBT apps / gym / nutrition counselling has higher ROI"Most expensive = best supplement" is usually a marketing premium — extract standardisation quality matters more
Connections to other atlas stories:
ashwagandha L4 (HPA + cortisol)endocrine/HPA + metabolic-syndrome (stress metabolism)insomnia + shift-work-circadian (sleep + rhythm)depression-anxiety + exercise (mental health)caffeine-l-theanine + alpha-gpc-cdp-choline (nootropic family)
Summary: the adaptogen field does include a few Level B-evidence items, but overall marketing far exceeds evidence. The atlas neither sells fear nor sells perfection — evaluate each item independently by evidence level, build foundations first, then consider supplements if room remains.
第一问: 你想解决什么
第一问: 你的目标是什么? 目标不同, 对应的东西完全不同。慢性应激、倦怠: Rhodiola B 级证据最强, Ashwagandha (atlas) 也是 B 级, 试一种 6-8 周轻度抑郁辅助: Rhodiola, 但不能替代 SSRI 或心理治疗认知、记忆: 狮鬃菇 C-B 级, 试 12 周; 效果远小于运动 + 睡眠 + 饮食免疫调节、慢性病辅助: 灵芝 C 级, 与传统医学结合运动耐力: Cordyceps 信号弱, 不要期望大效应抗衰、长生: 没有任何适应原达到这个标准, 不要买
第二问、第三问: 怎么试, 话术怎么看
第二问: 实际怎么用?一次试一种, 不要复合, 否则无法判断哪个起作用2-8 周评估: 主观感觉 + 应激量表、疲劳量表优先选有第三方质量认证的 (USP / NSF / Eurofins)优先标准化提取物, 不是全粉 或整体
第三问: 营销话术怎么看?
适应原万能调节: 概念太模糊, 实际单品作用窄整体智慧 + 古老传统: 历史悠久不等于现代证据强自然就是安全: 错, atlas 多次拆穿比药物温和又同样有效: 部分对, 大部分错抗痴呆、抗肿瘤、抗病毒万能: 严重夸大复合配方协同: 几乎没有大型 RCT 支持
Top 3 adaptogens
"Adaptogens" is a broad category, but only a few items have real RCT evidence. The atlas compares the top three "true adaptogens."① Rhodiola rosea · Level B:
Main actives: rosavin + salidrosideOlsson 2009 SHR-5 RCT (chronic fatigue, N=60): 200 mg 2/day × 4 weeks → ↓ fatigueEdwards 2012 acute stress: single 400 mg dose → ↑ mental-arithmetic + ↓ anxietyDose: 200-600 mg/day (morning)Suited to: stress-related fatigue + work pressureNot suited to: bipolar (mania risk) + pregnancy
② Ashwagandha (Indian ginseng) · Level B:
Main actives: withanolides (KSM-66 / Sensoril proprietary extracts)Chandrasekhar 2012 stress RCT: 300 mg 2/day × 60 days → cortisol ↓ 27%Salve 2019 sleep RCT: PSQI ↓Ambiye 2013 male T: 5 g × 12 weeks → T ↑ 17% (low-T baseline)Dose: 300-600 mg/dayWarning: 2024 Denmark + Nordics withdrew products (rare hepatotoxicity reports), monitor liver enzymesNot suited to: pregnancy (miscarriage risk) + autoimmune + hyperthyroidism
③ Panax ginseng · Level B:
Red ginseng / American ginseng / notoginseng (different species)Main actives: ginsenosides (Rb1, Rg1)Reay 2005 cognition RCT: 200 mg → ↑ working memoryKim 2013 chronic-fatigue RCT: 1-2 g/day × 4 weeks → total fatigue score did not beat placebo, but mental fatigue and the 2 g VAS did (P < 0.01)Vuksan 1999-2008: American ginseng + pre-meal → ↓ glucoseDose: red ginseng 1-3 g/day dry powder / standardised 200-400 mgCaution: may raise BP (individual variation) + affects INR
Comparison table:
| Rhodiola | Ashwagandha | Panax | |
|---|---|---|---|
| Strength | Stress + performance | Anxiety + sleep + T | Fatigue + elderly + glucose |
| Timing | Morning | Evening / with meal | Morning |
| Onset | 1-2 weeks | 4-8 weeks | 2-4 weeks |
| Pregnancy | Avoid | Strictly avoid | Avoid |
Pseudo-adaptogens (commercial hype, weak evidence):
Cordyceps (most RCTs negative)Reishi (some signal as cancer-adjunct, "adaptogen" label is weak)Astragalus (TCM "qi-tonic," weak modern evidence)"Complex adaptogen formulas" (mostly diluted)
Practice:
Stress + performance: Rhodiola 200 mg morning, 1-2 week trialAnxiety + sleep: Ashwagandha 300 mg evening, 6-8 week trialChronic fatigue + elderly: red ginseng 1-2 g morning, 2-4 week trialNo effect at 3 months → stopPregnancy / breastfeeding / bipolar / autoimmune / liver disease: avoid all
Safety warnings (all adaptogens)
下面这些对所有 适应原都成立:怀孕、哺乳: 大多数缺数据, 跳过双相、躁狂史: 部分可能诱发或加重服 SSRI / SNRI / MAOI: 理论上 5-HT 综合征风险抗凝药 (华法林 / DOAC): 部分适应原有抗血小板或影响凝血效应手术前停 1-2 周自身免疫病 (RA、红斑狼疮、桥本): 部分适应原会激活免疫, 慎用
这个钱值不值 · 接下来读哪篇
性价比方面: Ashwagandha 大约 $15-30 / 月、Rhodiola $20-40 / 月, 同等价钱花在 CBT app、健身房或营养咨询上性价比通常更高。最贵的就是最好的补剂 通常是营销溢价, 标准化提取物的质量更重要。与 atlas 其它故事的衔接:
ashwagandha L4 (hypothalamic–pituitary–adrenal axis: The body's stress-response chain (hypothalamus → pituitary → adrenal) that releases cortisol. + 皮质醇)endocrine / HPA + metabolic-syndrome (应激代谢)insomnia + shift-work-circadian (睡眠 + 节律)depression-anxiety + exercise (心理健康)caffeine-l-theanine + alpha-gpc-cdp-choline (nootropic 谱)
总的来说, 适应原赛道里确实有少数 B 级证据的单品, 但整体营销远超证据。这一岛既不卖恐慌也不卖完美——把每个单品按证据等级评估, 基础先做好, 有空间再考虑补剂。
References · 12
- Panossian, A., & Wikman, G. (2010). Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals, 3(1), 188-224. 10.3390/ph3010188
- Mori, K., Inatomi, S., Ouchi, K., Azumi, Y., & Tuchida, T. (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research, 23(3), 367-372. 10.1002/ptr.2634
- Saitsu, Y., Nishide, A., Kikushima, K., Shimizu, K., Ohnuki, K. (2019). Improvement of cognitive functions by oral intake of <i>Hericium</i><i> erinaceus </i>. Biomedical Research, 40(4), 125-131. Three tests: MMSE, Benton visual retention, S-PA verbal paired-associate. ONLY the MMSE reached significance — the two memory tests did not. The story used to print the reverse. 10.2220/biomedres.40.125
- Lai, P.-L., Naidu, M., Sabaratnam, V., Wong, K.-H., David, R. P., Kuppusamy, U. R., et al. (2013). Neurotrophic properties of the Lion's mane medicinal mushroom, Hericium erinaceus from Malaysia. International Journal of Medicinal Mushrooms, 15(6), 539-554. Erinacines and hericenones cross the BBB in animals and stimulate NGF/BDNF expression in cultured neurons. 10.1615/IntJMedMushr.v15.i6.30
- Olsson, E. M., von Schéele, B., & Panossian, A. G. (2009). A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Medica, 75(2), 105-112. 10.1055/s-0028-1088346
- Hung, S. K., Perry, R., & Ernst, E. (2011). The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine, 18(4), 235-244. Eleven placebo-controlled RCTs met inclusion: 6 on physical performance, 4 on mental performance, 2 in diagnosed mental-health conditions. Methodological quality mostly moderate or good, and only a few mild adverse events. ⚠️ The conclusion is deliberately weak: R. rosea MAY have beneficial effects, but there is a LACK OF INDEPENDENT REPLICATION of the individual studies and more research is warranted. Do not cite this review for consistency of effect — non-replication is its main finding. 10.1016/j.phymed.2010.08.014
- Jin, X., Ruiz Beguerie, J., Sze, D. M.-Y., & Chan, G. C. F. (2016). Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews, (4), CD007731. 10.1002/14651858.CD007731.pub3
- Salve, J., et al. (2019). Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus, 11(12), e6466. 10.7759/cureus.6466
- Ambiye, V. R., Langade, D., Dongre, S., Aptikar, P., Kulkarni, M., & Dongre, A. (2013). Clinical evaluation of the spermatogenic activity of the root extract of ashwagandha (Withania somnifera) in oligospermic males: a pilot study. Evidence-Based Complementary and Alternative Medicine, 2013, 571420. 10.1155/2013/571420
- Reay, J. L., Kennedy, D. O., & Scholey, A. B. (2005). Single doses of Panax ginseng reduce blood glucose levels and improve cognitive performance during sustained mental activity. Journal of Psychopharmacology, 19(4), 357-365. Panax ginseng 200mg reduced postprandial glucose and improved cognitive performance during sustained mental tasks; effects seen at 150-200mg; glucose-lowering consistent across studies. 10.1177/0269881105053286
- Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262. 10.4103/0253-7176.106022
- Kim, H.-G., Cho, J.-H., Yoo, S.-R., et al. (2013). Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebo-controlled trial. PLoS ONE, 8(4), e61271. 10.1371/journal.pone.0061271